Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka:4528) said once-daily 0.05, 0.1 and 0.15 mg doses of oral
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury